Cyclopropylboronic acid;2-[3-cyclopropyl-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid;methyl 2-[3-bromo-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetate
C45H60BBrN4O10 — CID 162112560
Data last refreshed: (MolForge compound catalog, from PubChem)
About Cyclopropylboronic acid;2-[3-cyclopropyl-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid;methyl 2-[3-bromo-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetate
Cyclopropylboronic acid;2-[3-cyclopropyl-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid;methyl 2-[3-bromo-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetate (PubChem CID 162112560) has the molecular formula C45H60BBrN4O10 and a molecular weight of 907.71 g/mol. Its IUPAC name is cyclopropylboronic acid;2-[3-cyclopropyl-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid;methyl 2-[3-bromo-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetate.
Molecular Properties
| Compound Name | Cyclopropylboronic acid;2-[3-cyclopropyl-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid;methyl 2-[3-bromo-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetate |
|---|---|
| PubChem CID | 162112560 |
| Molecular Formula | C45H60BBrN4O10 |
| Molecular Weight | 907.71 g/mol |
| Exact Mass | 906.36 |
| IUPAC Name | cyclopropylboronic acid;2-[3-cyclopropyl-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid;methyl 2-[3-bromo-4-(3,4-dihydro-2H-chromen-6-yl)-1-methylpyrazol-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetate |
| SMILES | COC(=O)C(OC(C)(C)C)c1c(-c2ccc3c(c2)CCCO3)c(Br)nn1C.Cn1nc(C2CC2)c(-c2ccc3c(c2)CCCO3)c1C(OC(C)(C)C)C(=O)O.OB(O)C1CC1 |
| InChI | InChI=1S/C22H28N2O4.C20H25BrN2O4.C3H7BO2/c1-22(2,3)28-20(21(25)26)19-17(18(13-7-8-13)23-24(19)4)15-9-10-16-14(12-15)6-5-11-27-16;1-20(2,3)27-17(19(24)25-5)16-15(18(21)22-23(16)4)13-8-9-14-12(11-13)7-6-10-26-14;5-4(6)3-1-2-3/h9-10,12-13,20H,5-8,11H2,1-4H3,(H,25,26);8-9,11,17H,6-7,10H2,1-5H3;3,5-6H,1-2H2 |
| InChIKey | ZGINRIRAVOVIQN-UHFFFAOYSA-N |
| XLogP | 8.06 |
| TPSA | 176.62 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 61 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 907.71 |
| LogP ≤ 5 | 8.06 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162112560 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.